Zynext Ventures Invests In Neuro42, A Company Developing Portable Mri Systems For Neuroimaging And Interventions

Zynext Ventures, the VC arm of Zydus Lifesciences, has invested in neuro42, a US-based company developing portable MRI systems for neuroimaging and interventions. neuro42’s technology promises to revolutionize procedures like brain biopsies and ablations, and their products are currently seeking regulatory clearance. The partnership between Zynext and neuro42 will accelerate the company’s mission to bring their innovative products to a global market.